Brooklyn, NY, United States of America

Yoshihide Yamanashi

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshihide Yamanashi in Antitumor Immunity

Introduction

Yoshihide Yamanashi is a notable inventor based in Brooklyn, NY. He has made significant contributions to the field of immunology, particularly in developing methods for inducing antitumor immunity. His innovative approach utilizes Sindbis viral vectors to enhance the immune response against tumors.

Latest Patents

Yamanashi holds a patent for a method aimed at treating mammals harboring tumors. The patent, titled "Method for inducing antitumor immunity using Sindbis viral vectors and tumor associated antigens," describes a process that involves identifying a tumor-associated antigen (TAA) expressed by the tumor. The method entails parenterally administering a therapeutically effective amount of a Sindbis viral vector carrying a gene encoding the TAA to elicit an immune response directed against the tumor, thereby treating the tumor effectively.

Career Highlights

Yoshihide Yamanashi is affiliated with New York University, where he continues to advance his research in immunotherapy. His work has garnered attention for its potential to improve cancer treatment outcomes through innovative methodologies.

Collaborations

Some of his notable coworkers include Daniel Meruelo and Tomer Granot, who contribute to the collaborative efforts in research and development within the field.

Conclusion

Yoshihide Yamanashi's contributions to antitumor immunity through his innovative patent highlight the importance of research in developing effective cancer treatments. His work exemplifies the intersection of science and technology in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…